ArticleInfectious diseases and therapy2020

Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial.

Matthew W McCarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.